Kromek Group PLC Issue of Equity and Total Voting Rights (0515O)
February 04 2021 - 9:00AM
UK Regulatory
TIDMKMK
RNS Number : 0515O
Kromek Group PLC
04 February 2021
4 February 2021
Kromek Group plc
("Kromek" or the "Company")
Issue of Equity and Total Voting Rights
Kromek Group plc, a worldwide supplier of detection technology
focusing on the medical, security screening and nuclear markets,
announces the issuance of 338,000 new ordinary shares (the
"Options") in the Company as a result of the exercise of employee
options during the period from 1 February 2019 to 17 July 2020.
Following the exercise of the Options, the Company's issued share
capital consists of 344,897,089 ordinary shares of 1p each. This
figure (344,897,089) may be used by shareholders as the denominator
for the calculations by which they will determine if they are
required to notify their interest in, or a change to, their
interest in the Company under the Financial Conduct Authority's
Disclosure Guidance and Transparency Rules.
Application has been made for a total of 2,008,000 new ordinary
shares to be admitted to trading on AIM ("Admission"). This number
is made up of the Options and a further 1,670,000 new ordinary
shares resulting from the historic exercise of options that were
not previously admitted to trading. It is expected that Admission
will occur on 10 February 2021. Following Admission, the Company
will have 344,897,089 ordinary shares in issue and admitted to
trading on AIM.
For further information, please contact:
Kromek Group plc
Arnab Basu, CEO +44 (0)1740 626
Paul Farquhar, CFO 060
Cenkos Securities plc (Nominated Adviser
and Broker)
Max Hartley (NOMAD)
Julian Morse (Sales) +44 (0)20 7397 8900
Luther Pendragon Ltd (PR)
Harry Chathli
Claire Norbury
Joe Quinlan +44 (0)20 7618 9100
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
IOEXZLFBFLLEBBK
(END) Dow Jones Newswires
February 04, 2021 09:00 ET (14:00 GMT)
Kromek (LSE:KMK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Kromek (LSE:KMK)
Historical Stock Chart
From Jul 2023 to Jul 2024